Cystic Fibrosis (CF) primarily affects the lungs and digestive system because of a malfunction in the exocrine system, responsible for producing saliva, sweat, tears and mucus.
There is currently no cure. People with CF develop an abnormal amount of excessively thick and sticky mucus within the lungs, airways and the digestive system. The mucus causes impairment of the digestive functions of the pancreas and traps bacteria in the lungs resulting in recurrent infections which lead to irreversible damage. Lung failure is the major cause of death for someone with CF.
From birth, a person with CF undergoes constant medical treatments and physiotherapy.
In Australia, one in 2,500 babies are born with CF, that’s one every four days. On average one in 25 people carry the CF gene - most of whom are unaware that they are carriers. Because carriers of CF are unaffected (and therefore show no symptoms) it is hard for them to appreciate that CF may be a real risk. Any of us could be a carrier and we wouldn’t know – think about it, that’s about 1 million unaware carriers – it could be you!
Since 1986, all newborns have been subject to a heel prick test. This test is used to screen for a number of conditions, one of which is an indicator for CF. Diagnosis may also result after a baby is born with obvious CF symptoms such a bowel blockage or failure to “thrive”. The heel prick test does not detect everyone; and the definitive test for CF continues to be The Sweat Test, as high levels of salt in perspiration is extremely common amongst those with CF.
Management and treatment of CF is lifelong, ongoing and relentless. A person with CF may consume up to 40 capsules daily to help digest food and may need to do up to three hours of airway clearance each day. It is important for people with CF to visit a CF treatment centre several times each year so that their progress can be monitored.
All this before they even start their normal daily activities like going to school or work.
People with CF are not encouraged to socialise with each other. The risk of cross-infection and exacerbation of lung conditions is too great. CF can be a lonely existence.
There is no cure for CF at present. Research is being conducted around the world, with large scale programs in both the USA and UK. In Australia, Cystic Fibrosis Victoria works through the Australian Cystic Fibrosis Research Trust, which supports over $500,000 of research a year across Australia.
Cystic Fibrosis came into the human genome about 5000 years ago and it has survived and spread. Today there are more than 1600 mutations that lead to CF, some of which are particular to individual families. At the other extreme, one mutation, Delta F508, is present in some 72% of all cases worldwide.
Carriers are symptomless and live normal lives. They are overwhelmingly unaware of their CF carrier status. Yet they have every chance of passing on the gene to the next generation and that generation to the next and so on – it is only a matter of time before a member of “ the family” is born with CF.
So what happens when two carriers have children...?
Two carrier parents have a 25% chance of having a child with CF with each pregnancy.
Where an infant receives the CF gene from just one parent, he/she will not be born with CF, but will throughout life, be a symptomless carrier of the CF gene like his/her parents.
Thinking children? Think carrier screening... For more information contact your local Cystic Fibrosis office or consult your doctor.